Evidence map›Paper›PMID 40836322›Full record

ArticleBMC bioinformatics2025

SV-MeCa: an XGBoost-based meta-caller approach for structural variant calling from short-read data.

Rudel Christian Nkouamedjo Fankep, Arda Söylev, Anna-Lena Kobiela, Jochen Blom, Corinna Ernst, Susanne Motameny

Abstract read
In one paragraph

Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Structural Variation and Its Roles in Plant Genomes.Plants (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rudel Christian Nkouamedjo FankepCenter for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Arda SöylevInstitute for Medical Biometry and Bioinformatics, Heinrich Heine University Düsseldorf, Medical Faculty, Düsseldorf, Germany.
Anna-Lena KobielaCenter for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Jochen BlomBioinformatics and Systems Biology, Justus Liebig University Gießen, Gießen, Germany.
Corinna ErnstCenter for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany. corinna.ernst@uk-koeln.de.
Susanne MotamenyCologne Center for Genomics, University of Cologne, Medical Faculty, Cologne, Germany. susanne.motameny@uni-koeln.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCalling structural variants (SVs), i.e., genomic alterations of ≥50bp, from whole genome short-read data remains challenging, as existing callers are known to lack accuracy and robustness. Therefore, meta-caller approaches combining the results of multiple standalone tools in a consensus set of reported SV calls, are widely used. Here, SV-MeCa (Structural Variant Meta-Caller) is presented, the first SV meta-caller incorporating variant-specific quality metrics from individual VCF outputs, rather than relying solely on number and combination of tools supporting consensus SV calls. In addition, SV-MeCa offers a suitable score to rank obtained consensus SV calls according to evidence of representing true positive calls, i.e., real-world variants.

resultsSV-MeCa applies seven standalone SV callers and merges resulting deletion and insertion calls into a union VCF file using SURVIVOR. For each entry in the SURVIVOR-generated consensus, caller-specific quality measures are extracted from corresponding standalone VCF files, and serve as input for an either deletion- or insertion-specific XGBoost decision tree classifier, which was previously trained on the HG002 SV benchmark data provided by the Genome in a Bottle consortium. The SV-MeCa XGBoost models assign a probability to (consensus) SV calls to represent true positive calls, which can be used for ranking the final output according to evidence. Performance of SV-MeCa and four previously published meta-caller approaches were evaluated based on autosomal SV calls in samples curated by the Human Genome Structural Variation Consortium, Phase 2. With regard to F[Formula: see text] scores, which were 0.58 on average for deletions and 0.42 on average for insertions, SV-MeCa outperformed the other meta-callers. With regard to precision, only ConsensuSV achieved higher values (0.97 versus 0.64 on average for deletions, 0.75 versus 0.53 on average for insertions), and with regard to recall, SV-MeCa was outperformed exclusively by Meta-SV for deletions (0.55 versus 0.53).

conclusionsSV-MeCa, publicly available at https://github.com/ccfboc-bioinformatics/SV-MeCa , outperforms existing SV meta-caller approaches by taking variant-specific quality measures into account. Moreover, due to the XGBoost prediction probabilities serving as scores, the output of SV-MeCa can be continuously adjusted to user needs in terms of sensitivity and precision.

Indexed as

GenomicsGenomic Structural VariationSoftwareAlgorithmsBoosting Machine Learning AlgorithmsGenome, HumanHumansMeta-callerStructural variantsVariant callingWhole-genome sequencing

Identifiers

PMID40836322
PMCPMC12366149

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.